Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials

Documenti analoghi

• Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: An updated systematic review and meta‐analysis of randomized controlled trials
  di: Wei Chen, et al.
  Pubblicazione: (2024)
• Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta‐analysis
  di: Shihan Wang, et al.
  Pubblicazione: (2024)
• Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials
  di: Ronnie Aronson, et al.
  Pubblicazione: (2025)
• Real‐world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement
  di: Sahana Mahesh, et al.
  Pubblicazione: (2025)
• The effect of glucagon‐like peptide‐1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta‐analysis
  di: Yu Zhang, et al.
  Pubblicazione: (2024)